Clicky

AxoGen, Inc.(AXGN)

Description: AxoGen, Inc. operates as a regenerative medicine company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve reconstruction solutions, including Avance Nerve Graft, a processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. The company's products are used by surgeons during surgical interventions to repair traumatic nerve injuries. It procures and processes its tissue products in the United States and markets in the United States, Canada, Switzerland, Austria, and Italy. AxoGen, Inc. is headquartered in Alachua, Florida.


Keywords: Organ Systems Regenerative Medicine Neurosurgery Nerve Nervous System Tissue Products Peripheral Nervous System Surgical Site Submucosa

Home Page: www.axogeninc.com

AXGN Technical Analysis

13631 Progress Boulevard
Alachua, FL 32615
United States
Phone: 386 462 6800


Officers

Name Title
Ms. Karen Zaderej Chairman, Pres & CEO
Mr. Peter J. Mariani Exec. VP & CFO
Ms. Maria D. Martinez Chief HR Officer
Mr. Angelo G. Scopelianos Ph.D. Chief R&D Officer
Mr. Michael Donovan VP of Operations
Ed Joyce Director of Investor Relations
Mr. Bradley L. Ottinger J.D. Gen. Counsel & Chief Compliance Officer
Mr. Gregory Davault VP of Marketing
Ms. Doris Quackenbush VP of Sales
Ms. Isabelle Billet Chief Strategy & Bus. Devel. Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.5561
Price-to-Sales TTM: 3.3809
IPO Date: 1990-03-27
Fiscal Year End: December
Full Time Employees: 428
Back to stocks